Marko Ušaj

875 total citations
30 papers, 628 citations indexed

About

Marko Ušaj is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Biotechnology. According to data from OpenAlex, Marko Ušaj has authored 30 papers receiving a total of 628 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Cardiology and Cardiovascular Medicine, 13 papers in Molecular Biology and 12 papers in Biotechnology. Recurrent topics in Marko Ušaj's work include Cardiomyopathy and Myosin Studies (16 papers), Microbial Inactivation Methods (12 papers) and Microfluidic and Bio-sensing Technologies (11 papers). Marko Ušaj is often cited by papers focused on Cardiomyopathy and Myosin Studies (16 papers), Microbial Inactivation Methods (12 papers) and Microfluidic and Bio-sensing Technologies (11 papers). Marko Ušaj collaborates with scholars based in Sweden, Slovenia and Israel. Marko Ušaj's co-authors include Maša Kandušer, Damijan Miklavčič, Arnon Henn, Alf Månsson, Dilson E. Rassier, Matej Reberšek, Lea Rems, Gorazd Pucihar, Ronit Regev and Ran Friedman and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Marko Ušaj

30 papers receiving 623 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marko Ušaj Sweden 15 316 234 202 151 59 30 628
Christian W. Zemlin United States 18 196 0.6× 185 0.8× 222 1.1× 304 2.0× 136 2.3× 49 762
Elena C. Gianulis United States 12 251 0.8× 217 0.9× 347 1.7× 149 1.0× 135 2.3× 16 566
Tamara Polajžer Slovenia 8 137 0.4× 224 1.0× 366 1.8× 60 0.4× 35 0.6× 16 563
Maura Casciola United States 21 273 0.9× 513 2.2× 726 3.6× 57 0.4× 222 3.8× 41 983
Liang Ji China 10 223 0.7× 97 0.4× 66 0.3× 21 0.1× 50 0.8× 19 623
Stine K. Frandsen Denmark 14 240 0.8× 271 1.2× 700 3.5× 9 0.1× 26 0.4× 19 854
Jiao Zhang China 14 392 1.2× 93 0.4× 21 0.1× 33 0.2× 73 1.2× 35 571
Philip M. Graybill United States 7 70 0.2× 225 1.0× 276 1.4× 5 0.0× 50 0.8× 10 430
Velia Siciliano Italy 17 832 2.6× 134 0.6× 29 0.1× 17 0.1× 53 0.9× 33 1.1k
Uma M. Mangalanathan United States 8 80 0.3× 131 0.6× 277 1.4× 7 0.0× 42 0.7× 13 330

Countries citing papers authored by Marko Ušaj

Since Specialization
Citations

This map shows the geographic impact of Marko Ušaj's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marko Ušaj with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marko Ušaj more than expected).

Fields of papers citing papers by Marko Ušaj

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marko Ušaj. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marko Ušaj. The network helps show where Marko Ušaj may publish in the future.

Co-authorship network of co-authors of Marko Ušaj

This figure shows the co-authorship network connecting the top 25 collaborators of Marko Ušaj. A scholar is included among the top collaborators of Marko Ušaj based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marko Ušaj. Marko Ušaj is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ušaj, Marko, et al.. (2024). Improved longevity of actomyosin in vitro motility assays for sustainable lab-on-a-chip applications. Scientific Reports. 14(1). 22768–22768. 1 indexed citations
2.
Ušaj, Marko, Mojca Pavlin, & Maša Kandušer. (2024). Feasibility Study for the Use of Gene Electrotransfer and Cell Electrofusion as a Single-Step Technique for the Generation of Activated Cancer Cell Vaccines. The Journal of Membrane Biology. 257(5-6). 377–389. 1 indexed citations
3.
4.
Ruijgrok, Paul V., Christoph Meinecke, Marko Ušaj, et al.. (2023). Exploitation of Engineered Light-Switchable Myosin XI for Nanotechnological Applications. ACS Nano. 17(17). 17233–17244. 3 indexed citations
5.
Månsson, Alf, et al.. (2023). New paradigms in actomyosin energy transduction: Critical evaluation of non‐traditional models for orthophosphate release. BioEssays. 45(9). e2300040–e2300040. 12 indexed citations
6.
Ušaj, Marko, et al.. (2022). Multistep orthophosphate release tunes actomyosin energy transduction. Nature Communications. 13(1). 4575–4575. 31 indexed citations
7.
Ušaj, Marko, et al.. (2021). Single molecule turnover of fluorescent ATP by myosin and actomyosin unveil elusive enzymatic mechanisms. Communications Biology. 4(1). 64–64. 16 indexed citations
8.
Huber, Tamás, et al.. (2020). Myosin and gelsolin cooperate in actin filament severing and actomyosin motor activity. Journal of Biological Chemistry. 296. 100181–100181. 14 indexed citations
9.
Kandušer, Maša, et al.. (2019). The Effect of Lipid Antioxidant α-Tocopherol on Cell Viability and Electrofusion Yield of B16-F1 Cells In Vitro. The Journal of Membrane Biology. 252(1). 105–114. 5 indexed citations
10.
Ušaj, Marko, et al.. (2018). Overexpression and purification of human myosins from transiently and stably transfected suspension adapted HEK293SF-3F6 cells. Analytical Biochemistry. 558. 19–27. 4 indexed citations
11.
Ušaj, Marko, et al.. (2018). Blebbistatin Effects Expose Hidden Secrets in the Force-Generating Cycle of Actin and Myosin. Biophysical Journal. 115(2). 386–397. 36 indexed citations
12.
Regev, Ronit, Marko Ušaj, P. Reinke, et al.. (2017). N-terminal splicing extensions of the human MYO1C gene fine-tune the kinetics of the three full-length myosin IC isoforms. Journal of Biological Chemistry. 292(43). 17804–17818. 14 indexed citations
13.
Ušaj, Marko & Arnon Henn. (2017). Kinetic adaptation of human Myo19 for active mitochondrial transport to growing filopodia tips. Scientific Reports. 7(1). 11596–11596. 15 indexed citations
14.
Ušaj, Marko, et al.. (2015). Myo19 is an outer mitochondrial membrane motor and effector of starvation-induced filopodia. Journal of Cell Science. 129(3). 543–556. 52 indexed citations
15.
Khoury-Haddad, Hanan, Marko Ušaj, Tali E. Haran, et al.. (2014). RNA-dependent chromatin localization of KDM4D lysine demethylase promotes H3K9me3 demethylation. Nucleic Acids Research. 42(21). 13026–13038. 28 indexed citations
16.
Kandušer, Maša & Marko Ušaj. (2014). Cell electrofusion: past and future perspectives for antibody production and cancer cell vaccines. Expert Opinion on Drug Delivery. 11(12). 1885–1898. 34 indexed citations
17.
Rems, Lea, Marko Ušaj, Maša Kandušer, et al.. (2013). Cell electrofusion using nanosecond electric pulses. Scientific Reports. 3(1). 3382–3382. 110 indexed citations
18.
Ušaj, Marko, Karel Flisar, Damijan Miklavčič, & Maša Kandušer. (2012). Electrofusion of B16-F1 and CHO cells: The comparison of the pulse first and contact first protocols. Bioelectrochemistry. 89. 34–41. 17 indexed citations
19.
Ušaj, Marko, et al.. (2010). Cell–Cell Electrofusion: Optimization of Electric Field Amplitude and Hypotonic Treatment for Mouse Melanoma (B16-F1) and Chinese Hamster Ovary (CHO) Cells. The Journal of Membrane Biology. 236(1). 107–116. 44 indexed citations
20.
Ušaj, Marko, et al.. (2010). Cell counting tool parameters optimization approach for electroporation efficiency determination of attached cells in phase contrast images. Journal of Microscopy. 241(3). 303–314. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christian W. Zemlin Breakdown of academic impact, for papers by Elena C. Gianulis Breakdown of academic impact, for papers by Tamara Polajžer Breakdown of academic impact, for papers by Maura Casciola Breakdown of academic impact, for papers by Liang Ji Breakdown of academic impact, for papers by Stine K. Frandsen Breakdown of academic impact, for papers by Jiao Zhang Breakdown of academic impact, for papers by Philip M. Graybill Breakdown of academic impact, for papers by Velia Siciliano Breakdown of academic impact, for papers by Uma M. Mangalanathan
Rankless by CCL
2026